Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Auto-Expandable Metallic Ureteral Stents for Complex Ureteral Stenosis: Long-Term Outcomes in a Tertiary Institution.

Urologia internationalis·2025
Same author

Case series of kidney transplantation in two pediatric recipients with rare genetic diseases and intellectual disability.

BMC pediatrics·2024
Same author

Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: A real-world data study.

European journal of neurology·2024
Same author

Renal cell carcinoma with an "uncoiling" tumor thrombus: intraoperative shift from level III to level IV.

World journal of surgical oncology·2024
Same author

Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.

Brain sciences·2021
Same author

Sexual Dysfunction in Early-Onset Parkinson's Disease: A Cross-Sectional, Multicenter Study.

Journal of Parkinson's disease·2020
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord
08:41

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord

Published on: May 12, 2018

[Candidate patient for subcutaneous apomorphine injection].

José R Chacón1, Marina Mata

  • 1Hospital Infanta Luisa, Sevilla, Espana.

Revista De Neurologia
|November 22, 2012
PubMed
Summary
This summary is machine-generated.

Subcutaneous apomorphine injection offers rapid relief for Parkinson's disease off episodes. This effective treatment is easily administered in outpatient settings after minimal training.

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

Related Experiment Videos

Last Updated: May 16, 2026

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord
08:41

Adeno-associated Virus-mediated Transgene Expression in Genetically Defined Neurons of the Spinal Cord

Published on: May 12, 2018

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder.
  • Motor fluctuations, including unpredictable "off" episodes, significantly impact patient quality of life.

Purpose of the Study:

  • To evaluate subcutaneous apomorphine injection as a rescue therapy for Parkinson's disease off episodes.
  • To assess the ease of use and outpatient applicability of this treatment.

Main Methods:

  • Review of subcutaneous apomorphine injection protocols.
  • Assessment of patient training requirements.
  • Analysis of implementation in outpatient neurological practice.

Main Results:

  • Subcutaneous apomorphine injection provides fast-acting rescue from both predictable and unpredictable PD off episodes.
  • The technique requires minimal training, making it user-friendly for patients.
  • Implementation in an outpatient setting is feasible following basic procedural guidelines.

Conclusions:

  • Subcutaneous apomorphine injection is a valuable, effective, and accessible treatment option for managing Parkinson's disease off episodes.
  • Neurologists can readily integrate this therapy into outpatient care for advanced PD patients.
  • This approach enhances patient autonomy and symptom management between scheduled appointments.